Previous 10 | Next 10 |
Vermillion, Inc. (VRML) Q1 2019 Earnings Conference Call May 14, 2019 4:30 PM ET Company Participants Valerie Palmieri – President and Chief Executive Officer Bob Beechey – Chief Financial Officer Chris Goulart – Senior Vice President-Commercial Operations ...
Vermillion (NASDAQ: VRML ): Q1 GAAP EPS of -$0.05. More news on: Vermillion, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
AUSTIN, Texas, May 14, 2019 (GLOBE NEWSWIRE) -- Vermillion, Inc. (NASDAQ: VRML), a bioanalytical-based women’s health company focused on gynecologic disease, today reported its financial results for the first quarter ended March 31, 2019. “We are very pleased by the recepti...
Data showing detection improvements across all populations, with marked improvement in detecting ovarian malignancy risk in the African American population Findings to be published in Biomarkers in Cancer AUSTIN, Texas, May 13, 2019 (GLOBE NEWSWIRE) -- Vermillion, Inc. (Nasdaq: V...
AUSTIN, Texas, April 22, 2019 (GLOBE NEWSWIRE) -- Vermillion, Inc. (Nasdaq: VRML), a bioanalytical-based women’s health company focused on gynecologic disease, today announced that it will report financial results for the first quarter ended March 31, 2019 on Tuesday, May 14, follo...
Gainers: Reebonz Holding (NASDAQ: RBZ ) +111% . Castor Maritime (NASDAQ: CTRM ) +43% . Anadarko Petroleum (NYSE: APC ) +33% . Immuron (NASDAQ: IMRN ) +27% . Enlivex Therapeutics (NASDAQ: ENLV ) +17% . Kitov Pharma (NASDAQ: KTOV ) +17% . Renren (NYSE: RENN ) +15% . Summit Wirel...
AUSTIN, Texas, April 02, 2019 (GLOBE NEWSWIRE) -- Vermillion, Inc. (NASDAQ: VRML), a bioanalytical-based women’s health company focused on gynecologic disease, is being represented at the 2019 American Association for Cancer Research Annual Meeting with a poster entitled “Ethn...
Vermillion, Inc. (VRML) Q4 2018 Earnings Conference Call March 28, 2019, 16:30 ET Company Participants Valerie Palmieri - CEO, President & Director Robert Beechey - CFO Conference Call Participants Michael Brcic - National Securities Corporation Presentation Operat...
Vermillion (NASDAQ: VRML ): Q4 GAAP EPS of -$0.04. More news on: Vermillion, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
AUSTIN, Texas, March 12, 2019 (GLOBE NEWSWIRE) -- Vermillion, Inc. (Nasdaq: VRML), a bioanalytical-based women’s health company focused on gynecologic disease, today announced that it will report financial results for the fourth quarter and year ended December 31, 2018 on Thursday,...
News, Short Squeeze, Breakout and More Instantly...
Total Revenue Increased 46% to $6.8 million; OVA1 Volume Grew 28% to 17,359 Units Exercise of option in the Harvard Dana-Farber Cancer Institute Collaboration Leadership and Board appointments implemented in First Quarter of 2022 Conference Call and Webcast sched...
AUSTIN, Texas, May 05, 2021 (GLOBE NEWSWIRE) -- Aspira Women’s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced that it will report financial results for the first quarter ended March 31, 2021 on Thursday, May 13, 2021, after the market...
AUSTIN, Texas, Sept. 08, 2020 (GLOBE NEWSWIRE) -- Aspira Women’s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced management will participate in the 2020 Cantor Virtual Healthcare Conference taking place on September 15-17, 2020. Valeri...